Addus HomeCare (NASDAQ:ADUS) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research report issued on Friday.
According to Zacks, “ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company’s services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing. “
ADUS has been the subject of several other research reports. BidaskClub downgraded shares of Addus HomeCare from a “hold” rating to a “sell” rating in a research report on Wednesday, January 31st. Stephens set a $56.00 price target on shares of Addus HomeCare and gave the stock a “buy” rating in a research report on Monday, April 2nd. Finally, Robert W. Baird set a $43.00 price target on shares of Addus HomeCare and gave the stock a “hold” rating in a research report on Wednesday, March 14th. Two equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $45.75.
ADUS stock opened at $52.50 on Friday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.90 and a current ratio of 2.90. Addus HomeCare has a 52-week low of $30.95 and a 52-week high of $54.99. The stock has a market cap of $622.25, a PE ratio of 36.21, a PEG ratio of 1.49 and a beta of -0.42.
Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, March 5th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.03. Addus HomeCare had a net margin of 3.20% and a return on equity of 9.95%. The business had revenue of $111.96 million for the quarter, compared to analyst estimates of $110.82 million. sell-side analysts forecast that Addus HomeCare will post 2.39 earnings per share for the current fiscal year.
In related news, EVP Darby Anderson sold 883 shares of the company’s stock in a transaction dated Wednesday, March 14th. The shares were sold at an average price of $43.25, for a total transaction of $38,189.75. Following the completion of the transaction, the executive vice president now owns 28,718 shares in the company, valued at approximately $1,242,053.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider James Zoccoli sold 725 shares of the stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $35.90, for a total transaction of $26,027.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 7,109 shares of company stock valued at $258,061. Insiders own 35.80% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in the business. Renaissance Technologies LLC raised its holdings in Addus HomeCare by 2.4% in the 4th quarter. Renaissance Technologies LLC now owns 72,800 shares of the company’s stock valued at $2,533,000 after acquiring an additional 1,700 shares during the last quarter. Victory Capital Management Inc. raised its holdings in Addus HomeCare by 6.7% in the 4th quarter. Victory Capital Management Inc. now owns 56,355 shares of the company’s stock valued at $1,961,000 after acquiring an additional 3,559 shares during the last quarter. MetLife Investment Advisors LLC acquired a new stake in Addus HomeCare in the 4th quarter valued at about $146,000. Thomson Horstmann & Bryant Inc. raised its holdings in Addus HomeCare by 3.3% in the 4th quarter. Thomson Horstmann & Bryant Inc. now owns 145,678 shares of the company’s stock valued at $5,069,000 after acquiring an additional 4,626 shares during the last quarter. Finally, BlackRock Inc. raised its holdings in Addus HomeCare by 1.1% in the 4th quarter. BlackRock Inc. now owns 437,855 shares of the company’s stock valued at $15,238,000 after acquiring an additional 4,670 shares during the last quarter. Institutional investors own 59.48% of the company’s stock.
TRADEMARK VIOLATION WARNING: This news story was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://ledgergazette.com/2018/04/15/zacks-investment-research-downgrades-addus-homecare-adus-to-hold.html.
About Addus HomeCare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.